Tags : Cipher Pharmaceuticals

Pharma

Cipher Pharmaceuticals Signs Exclusive License Agreement with Moberg Pharma for

Shots: Moberg to receive $14.6M as upfront and milestone payments of $4.6M for development and regulatory ($0.5M initial payment) and $10M on commercialization of product Moberg will be responsible for manufacturing the product while Cipher will take care of marketing, distribution and sales after completion of P-III trial and registration Moberg’s MOB-015 is a topical […]Read More